Sanofi and Regeneron Pharmaceuticals, Inc. today announced results from a pivotal Phase 3 study of sarilumab, an investigational, human antibody against the IL-6 receptor. The results of the...

- Positive one-year results show SB4 etanercept and SB2 infliximab investigational biosimilar candidates sustained comparable safety profiles observed in previously announced primary results Ÿ-...

- Compared to methotrexate, baricitinib as monotherapy or in combination with methotrexate demonstrated improvements in all ACR components as early as week 1 and maintained through 52 weeks - Both...

Nonin Medical,® the inventor of fingertip pulse oximetry and a leader in noninvasive medical monitoring, announced today that it has partnered with Tri-anim® Health Services to bring Nonin's new...

CareFusion, a BD company (NYSE:BDX), was presented today with the Zenith Award for the second year in a row from the American Association for Respiratory Care (AARC) at the 61st International...